Odyssean »

Ares Coml Real Estate shares owned by Odyssean

Quarter-by-quarter ownership of Ares Coml Real Estate (ACRE) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Ares Coml Real Estate

Tip: Access up to 7 years of quarterly data

All positions including Ares Coml Real Estate held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ares Coml Real Estate by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $659k 146k 4.50

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Ares Coml Real Estate

BlackRock
Vanguard Capital Management
Geode Capital Management
Hotchkis and Wiley Capital Management
State Street Corporation
North Ground Capital
Lighthouse Investment Partners
Cura Wealth Advisors
Alpine Partners VI
Colony
Van Eck Associates Corp.
Northern Trust
BI Asset Management Fondsmaeglerselskab A/S
Wellington Management Company
Vanguard Portfolio Management

View all funds holding Ares Coml Real Estate